Alaina Tedesco on Muck Rack

Alaina Tedesco

Thorofare
As seen in: Healio, Healio Cardiac/Vascular Intervention, Healio Gastroenterology, Healio Primary Care, HemOnc Today, Infectious Diseases News
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alaina

Contact Alaina, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

ACP: Physicians must promote patient safety

|
By Alaina Tedesco, Jack Ende, Sondra Zabar
| Healio Primary Care Verified
November 07, 2017 2 min read Save Perspective from ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Open in Who Shared Issue with article?

Burnout, dissatisfaction drive 1 in 5 physicians to plan on reducing work hours

|
By Alaina Tedesco
| Healio Primary Care Verified
November 10, 2017 3 min read Save ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Open in Who Shared Issue with article?

VIDEO: Blinatumomab demonstrates ‘remarkable’ results for pediatric B-cell ALL

|
By Alaina Tedesco
| HemOnc Today Verified
ORLANDO — In this video, Thomas Alexander, MD, pediatric oncologist and hematologist at the University of North Carolina, discusses a late breaking abstract presented at the ASH Annual Meeting and Exposition. The trial revealed “remarkable” increases in disease free survival and overall survival, as well as decreases in toxicity, among pediatric patients with B-cell acute lymphoblastic leukemia who were treated with blinatumomab.
Open in Who Shared Issue with article?
See all 646 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified